ARCHIVES

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

This article is from The Cancer Letter archive.

Vol. 09 No. 45 | November 25, 1983

Download PDF Visit The Full Archive

Related Articles

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

The White House: Justice Department May Sue Tobacco Firms, Clinton Says

January 22, 1999

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

Faulty Estimates Led NCI To Overstate Black-White Cancer Disparity In Atlanta

September 20, 2002

NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.

October 28, 2005